Skip to content

Clinical trials

Completed Neurodegenerative Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurodegenerative Diseases Status: Completed Country / region: United States Clear all

82 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20031
20041
20065
20075
20082
20093
20102
20112
20124
20134
20143
20155
20165
20178
20183
20195
20203
20214
20228
20234
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed82

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie5
Drexel University College of Medicine4
GenSight Biologics4
National Institute of Neurological Disorders and Stroke (NINDS)4
Tammie L. S. Benzinger, MD, PhD4
Alkahest, Inc.3
National Institute of Environmental Health Sciences (NIEHS)3
Alterity Therapeutics2
Amylyx Pharmaceuticals Inc.2
Johns Hopkins University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurodegenerative Diseases82
Nervous System Diseases30
Central Nervous System Diseases27
Alzheimer Disease24
Brain Diseases23
Movement Disorders22
Dementia21
Parkinson Disease21
Amyotrophic Lateral Sclerosis13
Parkinsonian Disorders10

Trials

Showing 1 to 25 of 82. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.